Servier had a strong presence at this year’s BIO International Convention, one of the world’s leading events for the biotech and pharmaceutical industry. With thousands of industry actors, investors, and decision-makers gathered in one place, BIO is a pivotal moment to shape conversations that matter. Servier took part in high-level panels and networking events throughout the week – highlighting our strategic priorities: advancing innovation in areas of high unmet need, strengthening international collaboration, and building lasting partnerships to better serve patients. 

Throughout the week, Servier leaders were featured across several panels and events: 

• Susan Pandya, Vice President, Clinical Development and Global Head of Oncology LS/LCM, took the stage at Voices from Biotech at the BIO Storytelling Stage – a session dedicated to amplifying inspiring stories from researchers, patients and caregivers, as well as company leaders on the newest biotech advancements. Susan shared Servier’s ongoing commitment to hard-to-treat and rare cancers, the role of cutting-edge technologies in making clinical research more efficient and inclusive, and how Servier contributes to the vitality of the Boston biotech ecosystem. 

• Cynthia Wang, Head of Business Development Asia, joined two key conversations centered on global innovation. At YAFO Capital’s Access China BD Forum, she participated in the Grasp the Wave – Unleash China’s Innovation Potential panel, an occasion to explore regional trends and Asia’s growing role in R&D advancements and investment opportunities. Cynthia also spoke at the BFC Global Healthcare Summer BD & Investment Conference, on the rise of Asian biotech scene, and why this market is a strategic priority for global pharma. Cynthia highlighted Servier’s early and ongoing efforts to build on Asian biotech innovation. 

• Irene Blat, Senior Director, Search & Evaluation at Servier Pharmaceuticals, took part in Business France’s panel on Unlocking Cross-Atlantic Innovation, sharing insight into building meaningful partnerships across borders. She emphasized the importance of understanding the US landscape, navigating cultural differences, and increasing visibility through initiatives like BIO.  

• David Lee, CEO Servier U.S., participated in the exclusive MIT CEO – Longwood Healthcare Leaders forum, a two-day high-level meeting gathering top executives, R&D heads, and academic leaders. David joined the session on Advancing Late-Stage Assets, contributing to conversations shaping the future of biotech development.